AAAAAA

   
Results: 1-3 |
Results: 3
Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era
Authors: Jani, AB Vaida, F Hanks, G Asbell, S Sartor, O Moul, JW Roach, M Brachman, D Kalokhe, U Muller-Runkel, R Ray, P Ignacio, L Awan, A Weichselbaum, RR Vijayakumar, S
Citation: Ab. Jani et al., Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era, INT J CANC, 96(6), 2001, pp. 363-371
Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the radiation therapy oncology group trials
Authors: Valicenti, R Lu, JD Pilepich, M Asbell, S Grignon, D
Citation: R. Valicenti et al., Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the radiation therapy oncology group trials, J CL ONCOL, 18(14), 2000, pp. 2740-2746
Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC):Identification of five groups with different survival
Authors: Werner-Wasik, M Scott, C Cox, JD Sause, WT Byhardt, RW Asbell, S Russell, A Komaki, R Lee, JS
Citation: M. Werner-wasik et al., Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC):Identification of five groups with different survival, INT J RAD O, 48(5), 2000, pp. 1475-1482
Risultati: 1-3 |